Current solutions are not working. According to the Substance Abuse and Mental Health Services Administration’s (SAMSHA’s) National Survey on Drug Use and Health:
- 23.5 million persons needed treatment for an illicit drug or alcohol abuse problem in 2009.
- From 2000-2010, the incidence of drug use in a group being treated for some form of mental illness was more than double that of the group that was not currently treated for mental illness – 25.8 percent vs. 12.1 percent.
- Drug abuse results in behavioral and biological health issues that affect individuals, families, and communities. Economic estimates indicate consequences from drug abuse approach 20% of our federal budget. (source NIDA)
- Ordering medication compliance testing can be time consuming for healthcare providers and is generally guided by treatment and medication lists; in addition, test ordering may overlook illicit medications and drugs not identified by patients.
- Compliance programs should be simple and actionable
- ADVISR identifies patients who should be tested – which lowers cost by focusing on those patients who are non-compliant.
- ADVISR simplifies test-ordering for providers, ensures only medically necessary testing is performed, and maximizes value of clinical data for outcome driven patient treatment.